Profile | GDS4284 / 221404_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 20.3511 | 13 |
GSM687648 | Patient 402 control | 115.277 | 38 |
GSM687653 | Patient 403 control | 107.633 | 37 |
GSM687658 | Patient 404 control | 117.839 | 37 |
GSM687663 | Patient 411 control | 52.7384 | 22 |
GSM687668 | Patient 422 control | 193.427 | 48 |
GSM687673 | Patient 424 control | 190.211 | 46 |
GSM687678 | Patient 425 control | 120.864 | 37 |
GSM687683 | Patient 427 control | 77.0346 | 28 |
GSM687688 | Patient 428 control | 133.302 | 40 |
GSM687695 | Patient 441 control | 244.804 | 44 |
GSM687699 | Patient 443 control | 123.025 | 34 |
GSM687704 | Patient 444 control | 240.783 | 52 |
GSM687707 | Patient 448 control | 244.942 | 49 |
GSM687712 | Patient 449 control | 97.1429 | 34 |
GSM687719 | Patient 450 control | 185.567 | 43 |
GSM687724 | Patient 451 control | 272.216 | 53 |
GSM687728 | Patient 452 control | 15.0179 | 8 |
GSM687646 | Patient 401 treated 24h | 63.5063 | 27 |
GSM687649 | Patient 402 treated 24h | 121.848 | 40 |
GSM687665 | Patient 411 treated 24h | 83.6923 | 29 |
GSM687651 | Patient 402 treated 4 weeks | 186.905 | 46 |
GSM687667 | Patient 411 treated 4 weeks | 108.15 | 35 |
GSM687670 | Patient 422 treated 24h | 106.674 | 34 |
GSM687671 | Patient 422 treated 4 weeks | 74.1839 | 30 |
GSM687654 | Patient 403 treated 24h | 88.9997 | 34 |
GSM687675 | Patient 424 treated 24h | 145.251 | 40 |
GSM687685 | Patient 427 treated 24h | 15.6418 | 10 |
GSM687656 | Patient 403 treated 4 weeks | 92.1751 | 35 |
GSM687677 | Patient 424 treated 4 weeks | 93.4268 | 33 |
GSM687687 | Patient 427 treated 4 weeks | 97.1578 | 36 |
GSM687692 | Patient 428 treated 4h | 81.9249 | 30 |
GSM687716 | Patient 449 treated 4h | 72.6691 | 28 |
GSM687722 | Patient 450 treated 4h | 121.57 | 35 |
GSM687680 | Patient 425 treated 24h | 102.674 | 35 |
GSM687690 | Patient 428 treated 24h | 89.5531 | 33 |
GSM687700 | Patient 443 treated 24h | 255.718 | 46 |
GSM687705 | Patient 444 treated 24h | 100.02 | 36 |
GSM687714 | Patient 449 treated 24h | 53.4433 | 25 |
GSM687721 | Patient 450 treated 24h | 166.079 | 40 |
GSM687682 | Patient 425 treated 4 weeks | 94.3408 | 34 |
GSM687694 | Patient 428 treated 4 weeks | 156.377 | 45 |
GSM687702 | Patient 443 treated 4 weeks | 182.912 | 44 |
GSM687718 | Patient 449 treated 4 weeks | 176.933 | 46 |
GSM687723 | Patient 450 treated 4 weeks | 93.9751 | 32 |
GSM687661 | Patient 404 treated 4h | 103.947 | 34 |
GSM687710 | Patient 448 treated 4h | 99.9126 | 34 |
GSM687726 | Patient 451 treated 4h | 121.088 | 35 |
GSM687730 | Patient 452 treated 4h | 154.345 | 29 |
GSM687660 | Patient 404 treated 24h | 178.748 | 41 |
GSM687697 | Patient 441 treated 24h | 240.265 | 46 |
GSM687709 | Patient 448 treated 24h | 15.1763 | 8 |
GSM687725 | Patient 451 treated 24h | 66.9668 | 24 |
GSM687729 | Patient 452 treated 24h | 28.6082 | 10 |
GSM687727 | Patient 451 treated 4 weeks | 171.401 | 42 |
GSM687731 | Patient 452 treated 4 weeks | 90.7397 | 30 |